JavadGlobal Regulatory Affairs Leader | Medical Device & Combination Product Development

...I left Amsterdam with a simple conclusion: the future of combination products will not be shaped by drug thinking alone or device thinking alone, but by how well we connect the two across development, regulation and the full lifecycle.

HoracioPrincipal Usability Researcher

Lots of good discussions, and quite a few questions around how we can optimize Human Factors processes while still maintaining the rigor needed for regulatory compliance. I really enjoyed the conversations around what that looks like in practice, especially when it comes to platforms, evidence reuse, and making submission preparation more efficient. Great organization by Etapa Pharma, and also really fun catching up with Javad, who did a great job presenting and keeping the discussions moving. A very good way to finish the conference week.

JamesDirector of Combination Product Development

The discussions around risk management were particularly valuable. Connecting device design decisions with formulation, usability and regulatory expectations gave us a much more complete perspective on combination product development.

IlkeOrganizational Leader in Medical Devices & Combination Products

Great to be attending the 8th Drug-Device Combination Products Conference in Amsterdam this week! What stands out is how many of the challenges we face are shared: navigating complex interfaces, bringing pharma & device quality and regulatory requirements together, managing lifecycle considerations, and finding practical ways to move forward.

AnandHead of Pharma

There was a lot of valuable information packed into the two days, so I am still digesting some of the insights and conversations. Many thanks to you and the team for the great organization.

JonQA Biologics lead & QP

It was a pleasure attending the Drug- Device forum and be able to exchange the different point of views and expectations between regulators, industry and NBOs. Thank you to Etapa Pharma for organising and putting together profesionals with such experience and background. Truly inspiring

VéroniqueCorporate RA Team Lead

I learned a great deal from both the speakers and the other attendees, met some wonderful people, and had the opportunity to expand my professional network. I would also like to highlight the excellent work of the three moderators, Javad, Kevin and Diane, who made the sessions and workshops particularly engaging and interactive.

ElenaDirector of Pharmaceutical Development

The real value was in bringing different disciplines into the same conversation. Formulation scientists, device experts and regulatory professionals were openly discussing the same development challenges from different perspectives - and that made the conversations much more productive.

Klaus UlrichDirector Global Business Development and Key Account Management | Drug Delivery & Medical Devices

It was a great conference. Thank you very much for the excellent organization and the highly informative and engaging presentations. I truly enjoyed the event and the valuable discussions throughout.

BernardChief Executive Officer & Scientific Lead

It was a pleasure to contribute to the discussion and explore why understanding real-world dosing behavior matters when we evaluate how forgiving a drug–device combination really is. Great discussions and exchanges throughout the event!

ThomasSenior Director, Drug Delivery

I particularly appreciated the connection between formulation challenges and device performance. The discussions made it clear that successful drug–device development requires these areas to be considered together from the very beginning